US Stock MarketDetailed Quotes

TFFP TFF Pharmaceuticals

Watchlist

1.8100
+0.0300+1.69%

Close Jul 3 13:00 ET

1.7700
-0.0400-2.21%

Post 15:52 ET

5.61MMarket Cap-192P/E (TTM)

TFF Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

295.25%203.27K

51.43K

Operating revenue

295.25%203.27K

--0

--51.43K

--0

Cost of revenue

Gross profit

Operating expense

-16.02%5.99M

-31.14%21.89M

-27.26%5.37M

-39.28%4.42M

-42.66%5.02M

-14.85%7.14M

0.03%31.8M

-26.90%7.38M

-16.10%7.28M

71.23%8.75M

Selling and administrative expenses

-18.32%2.32M

-23.41%10.57M

-29.48%2.51M

-32.12%2.27M

-27.40%2.67M

-11.62%2.84M

30.47%13.8M

11.59%3.56M

39.99%3.34M

56.45%3.68M

-General and administrative expense

-18.32%2.32M

-23.41%10.57M

-29.48%2.51M

-32.12%2.27M

-27.40%2.67M

-11.62%2.84M

30.47%13.8M

11.59%3.56M

39.99%3.34M

56.45%3.68M

Research and development costs

-14.50%3.67M

-34.79%12.06M

-28.09%2.97M

-40.72%2.39M

-47.44%2.68M

-17.94%4.3M

-13.17%18.5M

-40.23%4.14M

-36.50%4.03M

84.71%5.1M

Other operating expenses

----

-48.02%-733.87K

63.45%-114.33K

-168.04%-234.76K

-1,090.37%-333.35K

----

-462.39%-495.81K

-2,507.37%-312.78K

-75.17%-87.59K

-1,413.73%-28K

Operating profit

18.28%-5.79M

31.14%-21.89M

27.26%-5.37M

39.28%-4.42M

42.66%-5.02M

15.47%-7.09M

-0.03%-31.8M

26.90%-7.38M

16.10%-7.28M

-71.23%-8.75M

Net non-operating interest income expense

58.92%55.75K

895.91%266.19K

1,307.46%106.18K

1,351.38%88.81K

514.29%36.12K

388.23%35.08K

-47.83%26.73K

-21.52%7.54K

-49.22%6.12K

-58.21%5.88K

Non-operating interest income

58.92%55.75K

895.91%266.19K

1,307.46%106.18K

1,351.38%88.81K

514.29%36.12K

388.23%35.08K

-47.83%26.73K

-21.52%7.54K

-49.22%6.12K

-58.21%5.88K

Other net income (expense)

385.24K

500.11K

-77.45K

-37.42K

Gain on sale of security

----

--385.24K

----

Other non- operating income (expenses)

----

---77.45K

---37.42K

----

Income before tax

18.67%-5.74M

33.13%-21.24M

35.41%-4.76M

39.39%-4.41M

42.60%-5.02M

15.81%-7.05M

-2.36%-31.77M

26.63%-7.37M

16.18%-7.27M

-87.86%-8.75M

Income tax

Net income

18.67%-5.74M

33.13%-21.24M

35.41%-4.76M

39.39%-4.41M

42.60%-5.02M

15.81%-7.05M

-2.36%-31.77M

26.63%-7.37M

16.18%-7.27M

-87.86%-8.75M

Net income continuous Operations

18.67%-5.74M

33.13%-21.24M

35.41%-4.76M

39.39%-4.41M

42.60%-5.02M

15.81%-7.05M

-2.36%-31.77M

26.63%-7.37M

16.18%-7.27M

-87.86%-8.75M

Minority interest income

Net income attributable to the parent company

18.67%-5.74M

33.13%-21.24M

35.41%-4.76M

39.39%-4.41M

42.60%-5.02M

15.81%-7.05M

-2.36%-31.77M

26.63%-7.37M

16.18%-7.27M

-87.86%-8.75M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

18.67%-5.74M

33.13%-21.24M

35.41%-4.76M

39.39%-4.41M

42.60%-5.02M

15.81%-7.05M

-2.36%-31.77M

26.63%-7.37M

16.18%-7.27M

-87.86%-8.75M

Basic earnings per share

50.72%-2.4

55.27%-11.85

35.74%-1.6

68.97%-2.25

58.82%-3.5

40.97%-4.87

15.23%-26.49

75.10%-2.49

14.71%-7.25

-88.89%-8.5

Diluted earnings per share

50.72%-2.4

55.27%-11.85

35.74%-1.6

68.97%-2.25

58.82%-3.5

40.97%-4.87

15.23%-26.49

75.10%-2.49

14.71%-7.25

-88.89%-8.5

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	295.25%203.27K	0	0	0	0	51.43K	0	0	0	0
Operating revenue	295.25%203.27K	--0	--0	--0	--0	--51.43K	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-16.02%5.99M	-31.14%21.89M	-27.26%5.37M	-39.28%4.42M	-42.66%5.02M	-14.85%7.14M	0.03%31.8M	-26.90%7.38M	-16.10%7.28M	71.23%8.75M
Selling and administrative expenses	-18.32%2.32M	-23.41%10.57M	-29.48%2.51M	-32.12%2.27M	-27.40%2.67M	-11.62%2.84M	30.47%13.8M	11.59%3.56M	39.99%3.34M	56.45%3.68M
-General and administrative expense	-18.32%2.32M	-23.41%10.57M	-29.48%2.51M	-32.12%2.27M	-27.40%2.67M	-11.62%2.84M	30.47%13.8M	11.59%3.56M	39.99%3.34M	56.45%3.68M
Research and development costs	-14.50%3.67M	-34.79%12.06M	-28.09%2.97M	-40.72%2.39M	-47.44%2.68M	-17.94%4.3M	-13.17%18.5M	-40.23%4.14M	-36.50%4.03M	84.71%5.1M
Other operating expenses	----	-48.02%-733.87K	63.45%-114.33K	-168.04%-234.76K	-1,090.37%-333.35K	----	-462.39%-495.81K	-2,507.37%-312.78K	-75.17%-87.59K	-1,413.73%-28K
Operating profit	18.28%-5.79M	31.14%-21.89M	27.26%-5.37M	39.28%-4.42M	42.66%-5.02M	15.47%-7.09M	-0.03%-31.8M	26.90%-7.38M	16.10%-7.28M	-71.23%-8.75M
Net non-operating interest income expense	58.92%55.75K	895.91%266.19K	1,307.46%106.18K	1,351.38%88.81K	514.29%36.12K	388.23%35.08K	-47.83%26.73K	-21.52%7.54K	-49.22%6.12K	-58.21%5.88K
Non-operating interest income	58.92%55.75K	895.91%266.19K	1,307.46%106.18K	1,351.38%88.81K	514.29%36.12K	388.23%35.08K	-47.83%26.73K	-21.52%7.54K	-49.22%6.12K	-58.21%5.88K
Other net income (expense)		385.24K	500.11K	-77.45K	-37.42K
Gain on sale of security	----	--385.24K	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	----	----	----	---77.45K	---37.42K	----	----	----	----	----
Income before tax	18.67%-5.74M	33.13%-21.24M	35.41%-4.76M	39.39%-4.41M	42.60%-5.02M	15.81%-7.05M	-2.36%-31.77M	26.63%-7.37M	16.18%-7.27M	-87.86%-8.75M
Income tax
Net income	18.67%-5.74M	33.13%-21.24M	35.41%-4.76M	39.39%-4.41M	42.60%-5.02M	15.81%-7.05M	-2.36%-31.77M	26.63%-7.37M	16.18%-7.27M	-87.86%-8.75M
Net income continuous Operations	18.67%-5.74M	33.13%-21.24M	35.41%-4.76M	39.39%-4.41M	42.60%-5.02M	15.81%-7.05M	-2.36%-31.77M	26.63%-7.37M	16.18%-7.27M	-87.86%-8.75M
Minority interest income
Net income attributable to the parent company	18.67%-5.74M	33.13%-21.24M	35.41%-4.76M	39.39%-4.41M	42.60%-5.02M	15.81%-7.05M	-2.36%-31.77M	26.63%-7.37M	16.18%-7.27M	-87.86%-8.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	18.67%-5.74M	33.13%-21.24M	35.41%-4.76M	39.39%-4.41M	42.60%-5.02M	15.81%-7.05M	-2.36%-31.77M	26.63%-7.37M	16.18%-7.27M	-87.86%-8.75M
Basic earnings per share	50.72%-2.4	55.27%-11.85	35.74%-1.6	68.97%-2.25	58.82%-3.5	40.97%-4.87	15.23%-26.49	75.10%-2.49	14.71%-7.25	-88.89%-8.5
Diluted earnings per share	50.72%-2.4	55.27%-11.85	35.74%-1.6	68.97%-2.25	58.82%-3.5	40.97%-4.87	15.23%-26.49	75.10%-2.49	14.71%-7.25	-88.89%-8.5
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall